drugset / Trial / NCT04624672
Treatment of GLP-1 for Diabetic Bariatric Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is for patients that are diabetic, and require insulin for glycemic control, and going through the bariatric surgery process. This is a prospective study that is trying to determine if the introduction of a semaglutide increases the remission rates of diabetes post-operatively.
Timeline
- Start
- 2021-08-25
- Primary completion
- 2022-07-18
- Completion
- 2022-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Semaglutide | Peptide | 1 mg | Other |